The SMGs identified in our mouse models included well-described melanoma and leukemia oncogenes and tumour suppressors (Muc4, Pten, Grin2a, Dnmt3a, Npm1 and Flt3) [14–16] reinforcing the WES validation and the subsequent filtering of SMGs. This evidence concerns the gene GRIN2A and leukemia.